Sotac Pharmaceuticals

Sotac Pharmaceuticals EBIT CAGR 5Y

The EBIT CAGR (5 Year) of Sotac Pharmaceuticals (SOTAC.NS) as of Oct 19, 2026 is 84.29 %. In the previous year, EBIT CAGR (5 Year) was 84.29 % — a change of 0.00% (lower).

EBIT CAGR 5Y

84.29 %

YoY

0.00%

Last updated:

EBIT CAGR (5 Year) of Sotac Pharmaceuticals is 2025 84.29 % . EBIT CAGR (5 Year) of Sotac Pharmaceuticals was 2024 84.29 % . It decreases by 0.00% lower compared to the previous year.

The Sotac Pharmaceuticals EBIT CAGR 5Y history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT CAGR 5Y
Date
EBIT CAGR 5Y
Jan 1, 2020
84.29 INR
Jan 1, 2021
84.29 INR
Jan 1, 2022
84.29 INR
Jan 1, 2023
84.29 INR
Jan 1, 2024
84.29 INR
Jan 1, 2025
84.29 INR
The Sotac Pharmaceuticals EBIT CAGR 5Y history
YEAREBIT CAGR 5YYoY
84.29 %0.00%
84.29 %0.00%
84.29 %0.00%
84.29 %0.00%
84.29 %0.00%
84.29 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Sotac Pharmaceuticals Stock analysis

What does Sotac Pharmaceuticals do? Sotac Pharmaceuticals Ltd., headquartered in Ahmedabad, Gujarat, operates in the Health Care sector, specializing in pharmaceutical manufacturing. The company develops and manufactures products such as Non Beta-Lactam tablets, capsules, syrups, and external preparations on a contract basis for various marketers. Its therapeutic portfolio covers Anti-Diabetic, Anti-Psychotic, Vitamins, Minerals, Anti-Cold, Anti-Allergic, Derma Products, and a wide range of antibiotics including Non-IP-Lactams and Cephalosporin. Listed on 13 April 2023, Sotac employs 89 people and has subsidiaries including SOTAC Healthcare, SOTAC Research, and SOTAC Lifescience. Sotac Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sotac Pharmaceuticals stock

EBIT CAGR (5 Year) of Sotac Pharmaceuticals is 84.29 % in 2025.

On Eulerpool you can find the complete historical development of EBIT CAGR (5 Year) Sotac Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

The 5-year EBIT CAGR shows the compound annual growth rate of EBIT over the past five years.

To evaluate EBIT CAGR (5 Year)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT CAGR (5 Year).

EBIT CAGR (5 Year)'s is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT CAGR (5 Year)'s Sotac Pharmaceuticals historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Growth — Sotac Pharmaceuticals

Revenue GrowthRevenue CAGR 3YRevenue CAGR 5YRevenue CAGR 10YEarnings GrowthEPS GrowthEBIT GrowthEBIT CAGR 3YEBIT CAGR 5YEBIT CAGR 10YDividend GrowthFCF GrowthBook Value GrowthEarnings CAGR 3YEarnings CAGR 5YEarnings CAGR 10YEPS CAGR 3YEPS CAGR 5YEBITDA Growth YoYEBITDA CAGR 3YEBITDA CAGR 5YGross Profit GrowthOCF Growth YoYEmployee GrowthDividend CAGR 3YDividend CAGR 5YDividend CAGR 10YAsset GrowthEquity GrowthDebt GrowthCapEx GrowthFCF CAGR 3YFCF CAGR 5YMarket Cap GrowthShare Count Growth

All Key Metrics — Sotac Pharmaceuticals